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ABSTRACT
Purpose: In the framework of the ‘Realizing the European Network of Biodosimetry’ (RENEB) project,
two intercomparison exercises were conducted to assess the suitability of an optimized version of the
cytokinesis-block micronucleus assay, and to evaluate the capacity of a large laboratory network per-
forming biodosimetry for radiation emergency triages. Twelve European institutions participated in the
first exercise, and four non-RENEB labs were added in the second one.
Materials and methods: Irradiated blood samples were shipped to participating labs, whose task was
to culture these samples and provide a blind dose estimate. Micronucleus analysis was performed by
automated, semi-automated and manual procedures.
Results: The dose estimates provided by network laboratories were in good agreement with true
administered doses. The most accurate estimates were reported for low dose points ( 0.94Gy). For
higher dose points ( 2.7Gy) a larger variation in estimates was observed, though in the second exer-
cise the number of acceptable estimates increased satisfactorily. Higher accuracy was achieved with the
semi-automated method.
Conclusion: The results of the two exercises performed by our network demonstrate that the micronu-
cleus assay is a useful tool for large-scale radiation emergencies, and can be successfully implemented
within a large network of laboratories.
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Introduction
Radiological emergencies in which a large number of victims
are involved can occur as the result of different events such
as radiation accidents, terrorist attacks with dirty bombs or
other kinds of exposure to radioactive sources. In the event
of large radiological accidents, an initial triage aimed at classi-
fying victims according to the degree of exposure is indicated
to guide appropriate clinical responses. In the framework of a
previous EU FP7 project MultiBioDose, focusing on radiological
emergencies, three triage categories were considered: a low
dose category, for exposures to doses lower than 1Gy, requiring
no direct clinical treatment, a medium dose category, with doses
ranging from 1–2Gy, for which medical follow-up is necessary,
and a high dose category, following exposure to doses higher
than 2Gy, for which urgent medical intervention is mandatory
(Jaworska et al. 2015). Estimation of exposure to unknown radi-
ation doses based on symptoms of the prodromal stage such as
headache, nausea, diarrhea and others often result in misclassifi-
cation of the victims, as those symptoms can also be psycho-
genic of origin as a consequence of anxiety or may be absent
in spite of a significant exposure (International Atomic Energy
Agency [IAEA] 2011). Thus, confirmation of the victim’s exposure
status by means of biological dosimetry is necessary to comple-
ment clinical symptom evaluation (Voisin et al. 2001).
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In the case of large scale accidents, involving thousands of
victims, the capacity of a single biological dosimetry labora-
tory would be insufficient and the availability of a network of
biodosimetry laboratories would be an important element to
ensure the implementation of adequate emergency response
strategies (Roy et al. 2007; Blakely et al. 2009). The aim of the
RENEB (Realizing the European Network of Biodosimetry) pro-
ject was to establish such a network of European laboratories
that can ensure a harmonized performance of five biological
dosimetry assays (the dicentric chromosome assay; the FISH-
translocation assay; the micronucleus assay; the premature
chromosome condensation assay; the gamma-H2AX assay)
and two physical retrospective assays (electron paramagnetic
resonance and optically stimulated luminescence) for individ-
ual dose assessment. Within the RENEB network, these assays
have been further optimized through standardization of
methods, training and inter-comparison exercises (Kulka et al.
2012, 2015).
The cytokinesis-block (CB) micronucleus (MN) assay, origin-
ally developed by Fenech and Morley in 1985, is a valuable bio-
dosimetric tool for quantifying radiation-induced chromosomal
damage for population triage thanks to the simplicity of MN
scoring and the availability of automated MN analysis using
microscopy-based (Schunck et al. 2004; Varga et al. 2004;
Decordier et al. 2009; Willems et al. 2010) or flow cytometry-
based methods (Rodrigues et al. 2016). Also a high throughput
and miniaturized version of the CBMN assay for accelerated
sample processing has recently been described (Lue et al.
2015). At present, several studies have confirmed the reliability
of the automated MN assay for high throughput population tri-
age (Willems et al. 2010; Romm et al. 2013; Thierens et al. 2014;
Lue et al. 2015; Rodrigues et al. 2016, Wilkins et al. 2015).
In this paper the results of two intercomparison exercises
performed within the RENEB network using the CB micronu-
cleus assay are presented.
Materials and methods
Participating laboratories
Two separate intercomparison exercises (intercomparison 1,
or IC1, and intercomparison 2, or IC2) were performed to
assess the capacity of the RENEB network and the reliability
and homogeneity of dose estimations resulting from the
implementation of the CBMN assay. Twelve European institu-
tions participated in the first intercomparison. The same labs
were also involved in the second intercomparison with the
exception of one lab that was replaced by another lab partici-
pating in RENEB (lab 8). In the second intercomparison also
four new non-RENEB laboratories were included: two candi-
date EU labs, intending to join the network in the future, and
two partners from outside the EU.
Set-up of the intercomparison (IC) exercises
For the intercomparison exercises blood samples were irradi-
ated in vitro at the irradiation facility of one of the RENEB
labs. Samples were then shipped to all partner labs for proc-
essing, blind scoring and triage dose assessment. Different
exposure conditions (acute whole body, partial body) were
simulated and the biodosimetry analysis was performed by
automated, semi-automated or manual scoring of micronuclei.
The second intercomparison took place after a period of 18
months following the first exercise. Based on the results
obtained applying the different scoring methods in IC 1, areas
requiring additional training were identified.
Irradiations and shipment of the blood samples
Blood samples were irradiated at one of the RENEB labs with
Cs-137 gamma-rays (dose rate 0.478 Gy/min) at 37 C and left
for 2 h at 37 C to allow repair. The first intercomparison exer-
cise included four coded blood samples, covering four different
doses/irradiation schemes, while the second intercomparison
included only two coded blood samples. The participating lab-
oratories received the information that the blood samples con-
sisted of one sham-irradiated control, one low-dose specimen
(0.94Gy), one high-dose specimen (3.27Gy) and one partial-
body (PB) dose specimen (4.75Gy PB; for this irradiated blood
was mixed in a 1:1 ratio [50% irradiated blood volume]) in IC1.
In IC2, one low-dose (0.85Gy) and one high-dose specimen
(2.7Gy) were distributed to the participating organisations. The
coded samples were shipped to all partners (12 laboratories in
IC1 and 16 in IC2) according to packing instruction 650 for
Biological Substances, Category B. In each package a tempera-
ture logger and dosimeter (glass dosimeter, Type SC-2), were
also included. The minimum shipping temperature registered
was 1 C, the maximum temperature was 30 C.
Cytokinesis-block (CB) micronucleus assay
Upon receipt of the blood samples, individual laboratories were
requested to culture the coded blood specimens and analyze
the samples according to their standard protocols and scoring
criteria. Details about the MN protocols are summarized in
Table 1. Each laboratory then provided a dose estimate for
every sample using their own calibration curves. Laboratories
already had existing calibration curves or they were generated
just before the start of the exercises. Only one candidate EU lab
reported having no calibration curve and intended to use an
appropriate curve from the literature. The participants were
asked to set up two separate cultures per dose point and to
analyze two slides per culture. For the automated and semi-
automated (which implies the visual inspection of MN-positive
binucleate [BN] cells) analysis of DAPI-stained cells each labora-
tory was asked to score at least 1000 BN cells per slide. For the
manual analysis of Giemsa-stained cells, 500 BN cells per slide
were scored. Five laboratories performed both automated and
semi-automated MN scoring using the Metafer platform
(Metasystems, Altlussheim, Germany). These labs also partici-
pated in automated MN scoring for the FP7 MultiBioDose pro-
ject and used the same MN protocol and established
automated and semi-automated scoring procedure. The seven
remaining laboratories performed the standard MN assay using
their own in-house protocol and manual scoring procedures.
During IC2, three additional laboratories (one RENEB lab and
two non-RENEB partners) performed automated/semi-
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automated analysis and four non-RENEB partners performed
manual micronucleus scoring.
Results
MN dose-response curves
During IC1 the participants were asked to send to the coordi-
nating laboratory the radiation characteristics and the
coefficients of the linear-quadratic equation for their MN
dose-response calibration curve(s) (Table 2). The MN calibra-
tion curves of the 12 labs are shown in Figure 1: the graph
includes five curves obtained with automated scoring (black
curves: labs 1, 2, 4, 5 and 12); five curves obtained with semi-
automated scoring (green curves: labs 1, 2, 4, 5 and 12) and
seven curves obtained with manual scoring (blue/purple
curves: labs 3, 6–11). Nine calibration curves were set up by
exposing whole blood samples to Co-60 gamma-rays, two
were set-up after exposure to Cs-137 gamma-rays (lab 1 and
9) and only one was obtained after exposure to X-rays (lab 8,
IC1). In general, a large variation in the dose response curves
was observed for all scoring methods. By means of a Chi-
square test (Dose Estimate software), the homogeneity of the
MN dose response curves reported by the different labs
within each scoring group was analyzed. Among the different
curves, inhomogeneity was revealed (p-values <0.001) and
the level of inhomogeneity increased with increasing doses.
The highest level of inhomogeneity was observed for the
manual scoring method and may reflect the differences in
MN protocols, radiation conditions and scoring criteria used
by the different labs in this scoring group. The lowest level of
inhomogeneity was obtained for the automated scoring
group where a more standardized approach was applied.
MN yields obtained for the blood samples analyzed in
IC1 and IC2
In Table 3(a) and 3(b), the results of the CBMN assay (number
of MN/1000 BN cells and total number of BN cells scored)
obtained by all participating laboratories that analyzed the
four blind samples provided in IC1 (Table 3(a)) and the two
blind samples provided during IC2 (Table 3(b)) are summar-
ized. The data in Table 3 are grouped according to the
applied scoring method; the mean MN values ± SEM (standard
error of the mean) per dose point and per scoring method
are also shown. In Table 3(b), the mean MN values are given
separately for the participating RENEB labs alone as well as
for all labs together (RENEB and non-RENEB). The results of
Table 2. Radiation characteristics and coefficients of the MN dose response curves of the RENEB labs.
Lab. No. Radiation quality Dose rate (Gy/min) Irradiation temp (C) Scoring method a (±SE) b (±SE) c (±SE)
1 Cs-137 0.48 37 Automated 0.061 (±0.011) 0.016 (±0.004) 0.027 (±0.002)
Semi-auto 0.046 (±0.009) 0.032 (±0.004) 0.013 (±0.001)
2 60Co 0.4 37 Automated 0.057 (±0.011) 0.016 (±0.004) 0.011 (±0.004)
Semi-auto 0.068 (±0.016) 0.015 (±0.006) 0.039 (±0.007)
3 60Co 0.26 37 Manual 0.016 0.056 0.007
4 60Co 0.8 37 Automated 0.059 (±0.011) 0.002 (±0.003) 0.010 (±0.005)
Semi-auto 0.026 (±0.008) 0.012 (±0.003) 0.004 (±0.003)
5 60Co 1.27 37 Automated 0.029 (±0.012) 0.029 (±0.005) 0.038 (±0.005)
Semi-auto 0.033 (±0.009) 0.032 (±0.004) 0.009 (±0.003)
6 60Co 37 Manual 0.063 (±0.011) 0.014 (±0.006) 0.008 (±0.003)
7 60Co 0.14 RT Manual 0.024 (±0.002) 0.019 (±0.001) 0.012 (±0.001)
8 X-rays 1 RT Manual 0.082 (±0.02) 0.009 (±0.003) 0.022 (±0.008)
(200 kV, 4mA)
9 Cs-137 0.63 RT Manual 0.040 (±0.014) 0.017 (±0.004) 0.021 (±0.009)
10 60Co <0.5 37 Manual 0.097 (±0.003) 0.014 (±0.010) 0.030 (±0.004)
11 60Co 1 37 Manual 0.049 (±0.004) 0.045 (±0.002) 0.020 (±0.001)
12 60Co 0.5 37 Automated 0.079 (±0.018) 0.007 (±0.001) 0.023 (±0.016)
Semi-auto 0.061 (±0.008) 0.020 (±0.006) 0.002 (±0.005)
Table 1. Variations in the standard protocols of the CBMN assay between the participating labs in intercomparison 1 and 2.
Lab. No.
MN experience
(years) Medium FCS (%) Blood (%) Culture time (h)
Time cyto B
was added (h)
KClþ fixation
methanol: acetic acid Staining method
1 10 RPMI 10% 10% 72 24 KCl þ4:1 Dapi
2 5 RPMI 10% 10% 70 23 KCl þ4:1 Dapi
3 15 RPMI 10% 10% 72 24 KCl þ5:1 Giemsa
4 >20 RPMI 10% 8% 72 24 KCl þ4:1 Dapi
5 25 RPMI 10% 10% 70 23 KCl þ4:1 Dapi, giemsa
6 16 RPMI 10% 10% 72 44 KCl þ3:1 Giemsa
7 20 RPMI 25% 10% 72 44 3:1 Giemsa
8a >15 Ham’s F10 20% 10% 72 44 KCl þ3:1 Giemsa
9 15 RPMI 25% 10% 72 44 KCl þ3:1 Giemsa
10 10 RPMI 10% 5% 72 44 KCl þ3:1 Giemsa
11 20 RPMI 20% 10% 72 24 KCl þ4:1 Giemsa
12 25 RPMI 10% 10% 70 23 KCl þ4:1 Dapi
8b 2 RPMI 10% 5% 68 24 KCl þ3:1 Dapi
13 8 RPMI 10% 6% 72 44 KCl þ3:1 Dapi, giemsa
15 22 RPMI 10% 10% 70 23 KCl þ4:1 Dapi
16 21 PB MAX – – 72 23 KCl þ3:1 Giemsa
L8a is the lab participating in IC1, L8b is the lab participating in IC2.
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lab 14 (a candidate EU lab) are not included as the yield of
BN cells reported by this group was too low. Moreover, lab
14 had provided no MN calibration curve at the time of the
exercise.
From Table 3(a) and 3(b) it can be observed that there
exists considerable inter-laboratory variation in MN yields
irrespective of the scoring method adopted. In IC1, compari-
son of the mean MN scores obtained with the three different
scoring methods for the sham-irradiated and low-dose sam-
ple, shows that the highest MN yields were obtained with the
automated scoring method, while the semi-automated and
manual method yielded comparable results. For the high-
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Figure 1. Micronucleus calibration curves of the RENEB participating labs (L). Calibration curves are shown for automated (black lines), semi-automated (green lines)
and manual (blue/purple lines) scoring methods. Labs 1, 2, 4, 5, 12 provided calibration curves for automated and semi-automated scoring. Labs 3, 6–11 provided cali-
bration curves for manual micronucleus scoring. One calibration curve (L8) was set up for 200 kV X-rays, nine calibration curves were set up for Co-60 gamma-rays
and two calibration curves (L1, L9) were set up for Cs-137 gamma-rays.
Table 3(a). Number of scored binucleate (BN) cells and observed micronucleus frequencies (micronuclei (MN)/1000 BN cells), stratified by scoring procedure for all
labs participating in the first intercomparison. Mean MN frequencies ± SEM per scoring procedure are also presented.
0 Gy 0.94 Gy 3.27 Gy 4.75 Gy PB
Scoring method Laboratory MN/1000 BN BN MN/1000 BN BN MN/1000 BN BN MN/1000 BN BN
Automated L1 54 2000 119 2999 480 2000 92 4000
L2 17 3499 107 5069 469 2847 99 5130
L4 112 4614 153 4903 439 3493 215 3988
L5 53 3980 72 3794 206 3578 62 4373
L12 23 3925 102 4011 439 1967 86 3996
Mean MN± SEM 52 ± 17 111 ± 29 407 ± 113 111 ± 60
Mean MN± SEM (without L4) 37 ± 10 100 ± 20 399 ± 129 85 ± 16
Semi-automated L1 39 2000 99 2999 593 2000 107 4000
L2 11 3499 85 5069 443 2847 94 5130
L4 34 4614 71 4903 349 3493 89 3988
L5 7 3980 45 3794 158 3578 19 4373
L12 19 3924 99 4005 507 1945 79 3992
Mean MN± SEM 22 ± 6 80 ± 10 410 ± 74 78 ± 15
Mean MN± SEM (without L4) 19 ± 7 82 ± 13 425 ± 94 75 ± 19
Manual L3 16 2000 32 2000 282 2000 72 2000
L6 18 2000 112 2000 753 2000 187 2000
L7 3 2000 78 2000 492 2000 136 2000
L8 20 1000 142 1000 843 1000 376 1000
L9 16 2000 55 2000 729 2000 77 2000
L10 28 1500 113 1000 654 1003 206 1005
L11 45 1298 54 1016 335 1001 135 1009
Mean MN± SEM 21 ± 5 84 ± 15 584 ± 82 170 ± 39
PB: partial body (50%).
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY 39
dose and the partial-body simulated sample, the manual scor-
ing method yielded higher MN scores compared to the semi-
automated and the automated scoring methods. This was
also the case for the high-dose point in IC2. In general, the
MN ranges were smaller with the semi-automated MN scoring
method at all dose points.
Dose estimations
The MN scores resulting from the assessment of all samples
were converted to dose estimates by the participants on the
basis of the individual laboratories calibration curves using
the software packages ‘Dose estimate_v5.1’ (Ainsbury and
Lloyd 2010) or ‘CABAS v2.0’ (Deperas et al. 2007).
A first result in respect to the dose estimations is that all
labs, when reporting their data to the coordinating partner,
correctly classified which sample was the control, the low-
dose, high-dose and partial-body dose.
In Table 4(a) and 4(b), the individual estimated doses
assessed in each laboratory are listed according to the differ-
ent scoring procedures for the two intercomparison exercises.
The mean dose estimates ± SEM per dose point and scoring
method are also shown. In Table 4(a) (IC1), mean values for
the automated or semi-automated scoring methods are also
calculated excluding the data of lab 4, as this lab reported
overestimations for all the dose points. In Table 4(b) (IC2), the
mean dose estimates ± SEM are shown, including or excluding
the non-RENEB partners.
To investigate which dose estimates would be acceptable
for triage, we used an uncertainty interval equal to 0.5 Gy for
doses lower than 2.5 Gy and an uncertainty interval equal to
a 20% deviation from the true dose for doses higher than
2.5 Gy. These uncertainty intervals have been reported for tri-
age dosimetry using chromosomal aberrations (Lloyd et al.
2000; Romm et al. 2013). Accordingly, in this study we used
the 0.5 Gy uncertainty intervals for the sham-irradiated and
the low-dose samples (0.85 Gy, 0.94 Gy) and the 20% devi-
ation from the true dose for the high-dose samples (2.7 Gy,
3.27 Gy and 4.75Gy PB). The dose estimates that were
unacceptable based on these uncertainty intervals are high-
lighted in grey in Table 4(a) and 4(b).
Table 4(a), illustrates the dose estimates obtained during
IC1. It shows that the number of acceptable dose estimates is
high for the sham-irradiated (15/17 dose estimates, 88%) and
low-dose sample of 0.94Gy (15/17 dose estimates, 88%). For
the high-dose sample the number of acceptable dose esti-
mates is lower (8/17, 47%). The lowest number of acceptable
dose estimates was obtained for the PB dose simulated sam-
ple (6/17 doses (35%) were correctly estimated). In IC2 (data
shown in Table 4(b)) the accuracy of the dose estimates for
Table 3(b). Number of scored binucleate (BN) cells and observed micronucleus frequencies (micronuclei (MN)/1000 BN cells), stratified by
scoring procedure for all labs participating in the second intercomparison. Mean MN frequencies ± SEM per scoring procedure are also
presented.
0.85 Gy 2.7 Gy
Scoring method Laboratory MN/1000BN BN MN/1000BN BN
Automated L1 86 4000 352 4000
L8 45 4025 170 3036
L4 62 3782 199 2623
L5 58 4371 271 4386
L12 104 3985 438 3987
L2 60 8382 245 6351
L13 63 1309 288 772
L15 142 4000 439 2959
Mean MN± SEM 78 ± 11 300 ± 36
Mean MN and BN± SEM (without L13, L15) 69 ± 9 279 ± 41
Semi-automated L1 82 4000 384 4000
L8 56 4025 286 3036
L4 52 3782 204 2623
L5 49 4371 292 4386
L12 83 3982 420 3974
L2 56 8381 260 6350
L13 82 1297 443 759
L15 61 3967 272 2817
Mean MN± SEM 65 ± 5 320 ± 30
Mean MN± SEM (without L13, L15) 63 ± 6 308 ± 33
Manual L3 88 2000 269 2000
L5 59 1066 356 1043
L6 106 2000 458 2000
L7 24 2000 100 2000
L9 87 1000 441 1000
L10 139 2218 500 2160
L11 91 2127 413 2184
L13 97 2000 600 2000
L15 165 2000 699 2000
L16 142 2000 421 2000
Mean MN± SEM 100 ± 13 426 ± 52
Mean MN± SEM (without L13, L15, L16) 85 ± 14 362 ± 52
Total
Mean MN± SEM 82 ± 7 3310 ± 371 355 ± 26
Mean MN± SEM (without L13, L15, L16) 73 ± 6 3658 ± 461 319 ± 25
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the low-dose point of 0.85 Gy was in line with that of IC1,
with 16/19 dose estimates (84%) lying within the defined tri-
age confidence intervals. For the high-dose point of 2.7 Gy in
IC2, the number of acceptable dose estimates increased com-
pared to IC1: 14/19 (74%) vs. 8/17 (47%). When comparing
the results obtained with the different scoring methods, it
appears that in both intercomparison exercises semi-auto-
mated analysis, which implies the visual inspection of MN-
positive BN cells, is the best method for triage purposes. In
IC2, all dose estimates were correctly classified by the RENEB
labs with the semi-automated method.
Two of the non-RENEB partners (lab 13, 15) reported
results for the semi-automated and manual scoring method,
while one lab (lab 16) only performed manual MN scoring.
The non-RENEB partners reported satisfactory dose estimates
for the low-dose point (4/5, 80%). The dose estimates for the
high-dose point were however less accurate with only one
out of five being correctly classified, although lab 15 received
the samples 3 days after irradiation, it reported acceptable
dose estimates for the 0.85 Gy dose with the two scoring
methods used. For the high-dose point the dose estimates
given by lab 15 were too high (outside the 20% uncertainly
interval). The dose estimates reported by lab 16 were too
high for both dose points.
Estimation of partial-body (PB) simulated dose
To identify the PB dose simulated sample, r2/l values calcu-
lated by Dose estimate and CABAS software were used. The
software also allows calculating the estimated partial body
dose and the fraction of the body irradiated. High values of
r2/l (1.8–2.5) were taken as being indicative for PB dose
irradiation with the MN assay (Thierens et al. 2014). In Figure 2,
the r2/l values are shown for the four dose points of IC1. Per
dose point, the r2/l values are grouped per scoring method.
For the PB simulated sample, r2/l 1.5 were obtained by all
labs (except one) while for the whole body simulated samples,
r2/l< 1.5 were obtained in 46 out of 51 measurements. Of
these 46 measurements, only six values of r2/l were <1. The
obtained partial body dose estimates were very variable (range:
2.28–7.89Gy; excluding lab 4) with 9/15 (60%) (excluding lab
4) dose estimates being unacceptable based on the 20% devi-
ation from the true dose (Table 4(a)). For the fraction of the
body irradiated a total mean value of 55% was obtained (50%
automated; 49% semi-automated; 62% manual), with values
ranging between 31 and 75%, excluding two outliers of 12
and 97%.
Laboratory performances
To compare the lab performances in dose estimation the
z-test was applied on the datasets from the IC1 and IC2 exer-
cises. A z-score of the dose was calculated for each dose esti-
mate obtained by the different scoring methods in order to
classify the estimates provided by a single laboratory as satis-
factory (j z j  2), questionable (2 < j z j < 3), or unsatisfactory
(j z j  3) (IAEA 2011; Garcia et al. 2012; Romm et al. 2013).
The results of this analysis are shown in Figure 3(a) and (b).
Table 4(a). Individual dose estimates reported by the laboratories participating in the first intercomparison exercise (laboratories:
L1–L12), stratified by scoring procedure. Mean dose estimates ± SEM per scoring procedure are also presented.
Estimated doses (Gy)
True doses (Gy)
Scoring method Laboratory 0 Gy 0.94 Gy 3.27 Gy 4.75 Gy PB
Automated L1 0.39 1.14 3.71 4.59
L2 0.00 0.82 3.55 5.01
L4 1.65 2.29 6.27 13.60
L5 0.39 0.71 1.98 2.28
L12 0.00 0.93 3.88 7.29
Mean ± SEM 0.49 ± 0.30 1.18 ± 0.29 3.88 ± 0.69 6.55 ± 1.93
Mean ± SEM (without L4) 0.20 ± 0.11 0.90 ± 0.09 3.28 ± 0.44 4.79 ± 1.03
Semi-automated L1 0.43 1.07 3.59 6.19
L2 0.00 1.01 3.71 7.04
L4 0.83 1.50 4.33 7.29
L5 0.00 0.66 1.70 4.81
L12 0.26 1.16 3.75 7.63
Mean ± SEM 0.30 ± 0.15 1.08 ± 0.14 3.42 ± 0.45 6.59 ± 0.51
Mean ± SEM (without L4) 0.17 ± 0.11 0.97 ± 0.11 3.19 ± 0.50 6.42 ± 0.61
Manual L3 0.16 0.41 2.79 5.86
L6 0.00 1.29 5.39 7.89
L7 0.00 1.32 4.40 5.62
L8 0.10 1.09 3.83 5.90
L9 0.00 0.67 5.39 5.24
L10 0.00 1.00 4.00 5.60
L11 0.38 0.47 2.10 3.23
Mean ± SEM 0.09 ± 0.05 0.89 ± 0.14 3.99 ± 0.47 5.62 ± 0.52
Mean TOTAL± SEM 0.27 ± 0.10 1.03 ± 1.11 3.79 ± 0.29 6.18 ± 0.59
Mean TOTAL± SEM (without L4) 0.14 ± 0.04 0.92 ± 0.07 3.59 ± 0.27 5.61 ± 0.39
Uncertainty interval for triage dose estimation.
0.5 Gy for 0 Gy and 0.94 Gy.
20% of true dose for the higher doses: 0.65 Gy for 3.27 Gy and 0.95 Gy for 4.75 Gy.
grey: dose estimates lying outside the uncertainty interval.
PB: partial body (50%).
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Figure 2. Variance/mean (r2/l) values, representing the overdispersion of the MN frequency distribution with respect to the Poisson distribution, are shown for the
sham-irradiated control (0 Gy), the total body simulated (0.94 Gy, 3.27 Gy) and partial body (PB) simulated (4.75 Gy) exposures of the first intercomparison. Per dose
point, the r2/l values are grouped per scoring method: automated scoring (black symbols), semi-automated scoring (green symbols), manual scoring (blue symbols).
Values of r2/l 1.5 (dotted line) were taken as being indicative for partial body exposure.
Table 4(b). Individual dose estimates reported by the laboratories participating in the second intercomparison exercise (labo-
ratories: L1–L16), stratified by scoring procedure. Mean dose estimates ± SEM per scoring procedure are also presented.
Estimated doses
True doses (Gy)
Scoring method Laboratory 0.85 2.7
Automated L1 0.87 2.72
L8 0.27 2.82
L4 0.46 2.39
L5 0.48 2.73
L12 1.15 3.42
L2 0.29 2.09
Mean ± SEM (Gy) 0.58 ± 0.14 2.69 ± 0.18
Semi-automated L1 1.00 2.55
L8 0.51 2.86
L4 0.95 3.03
L5 0.85 2.79
L12 1.15 2.79
L2 0.66 2.55
L13 0.66 2.05
L15 1.17 3.65
Mean ± SEM (Gy) 0.87 ± 0.09 2.78 ± 0.16
Mean ± SEM (Gy) (without L13, L15) 0.85 ± 0.1 2.76 ± 0.08
Manual L3 1.10 2.69
L5 0.83 3.09
L6 0.92 2.40
L7 0.38 1.59
L9 1.13 3.94
L10 0.99 3.29
L11 0.76 2.37
L13 0.70 2.35
L15 1.34 3.53
L16 2.03 4.10
Mean ± SEM (Gy) 1.02 ± 0.14 2.94 ± 0.25
Mean ± SEM (Gy) (without L13, L15, L16) 0.87 ± 0.10 2.77 ± 0.29
Mean TOTAL ± SEM (Gy) 0.86 ± 0.08 2.82 ± 0.12
Mean TOTAL ± SEM (Gy) (without L 13, L 15, L 16) 0.78 ± 0.07 2.74 ± 0.12
Uncertainty interval for triage dose estimation.
0.50 Gy for 0.85 Gy.
0.54 Gy for 2.7 Gy (20% of the true dose).
Grey: values lying outside the uncertainty interval.
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Most RENEB labs reported satisfactory results (j z j  2), with
only seven out of 106 z-scores being questionable and one
being unsatisfactory. Among the non-RENEB partners, two out
of 10 z-scores were questionable and one z-score was
unsatisfactory.
Number of slides/cells scored
Since, in the framework of triage biodosimetry, the speed of
reporting results is a crucial issue we investigated if there was
a difference in the accuracy of the dose estimate when scor-
ing MN on four, two or one slides. The results of this analysis
are shown in Figure 4(a–c) for automated, semi-automated
and manual analysis of the two blind samples from IC2. The
distribution of dose estimates in the correct or incorrect tri-
age category was not significantly different when four, two or
one slides were scored (Chi-square test, all p values >0.44)
and this was similar for all scoring methods. The time-to-score
one slide takes approximately 10minutes (min) in automated
mode (¼ time to focus and scan the slide), 15min in semi-
automated mode (10min to scan and about 5min to check
visually the BN cells with MN in the gallery display) and
30min in manual mode (500 BN cells).
Discussion
The intercomparison exercises performed by the RENEB net-
work provided an opportunity to compare the accuracy in
radiation dose estimation evaluated by means of the MN
assay. This evaluation included a large number of participants
(IC1, n¼ 12; IC2, n¼ 16), three different MN scoring methods,
and two different exercises performed at an interval of
18 months. Recently many intercomparisons have been per-
formed for triage biological dosimetry for the dicentric assay –
the gold standard technique for biological dosimetry – a
Figure 3. z-scores obtained in the first (a) and second (b) intercomparison exercise for the comparison of individual labs’ dose estimates with the true dose. The
z-scores of all the participating labs are given for the different dose points and scoring methods [automated (black symbols), semi-automated (green symbols) or man-
ual (blue symbols)]. Dose estimates are classified as satisfactory (j z j  2), questionable (2 < j z j < 3), and unsatisfactory (j z j  3).
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more limited number of intercomparison trials have been set
up for the MN assay (Willems et al. 2010; Romm et al. 2013;
Thierens et al. 2014; Wilkins et al. 2015). In most of these
intercomparisons only a small number of labs were involved
(2–6) and often only one scoring procedure, manual or auto-
mated, was investigated, without repetition of the exercise.
Only in one Canadian study, annual intercomparisons have
been conducted, although here the number of involved labs
was small (three labs) (Wilkins et al. 2015). As the ultimate
goal of RENEB was to specifically assess the competence and
capacity of a large network with facilities of an international
standard, including partners with different backgrounds
(Universities, National Radiation Protection Institutes, Military
centers, etc.) and expertise, the intercomparison exercises were
primarily not conducted in ‘real time’. All labs, however,
reported their results (MN scores and dose estimates) within a
fixed deadline (±1 month) set by the coordinating laboratory.
Well-defined standard procedures for packaging, labeling
and shipping of biological samples by air in Europe were set
up in a previous program on biodosimetry (EU FP7
MulitBioDose project) that included five RENEB laboratories.
The present, larger scale IC exercises, were also an excellent
opportunity to re-test the efficiency of worldwide shipment of
critical biological samples. The majority of shipments arrived
on time (within 24 h) in IC1 and IC2 however, two labs
received the blood samples with an extra delay of 24 (IC1:
L12) or 48 h (IC2: L15). No problems with culturing were how-
ever reported. One lab did not receive the samples and new
samples were sent.
To perform the blind dose estimation on the samples,
each lab used its own MN calibration curve, because at the
start of the project a large variation in calibration curves was
observed for all scoring methods. As nine calibration curves
were set up for Co-60 gamma-rays, two for Cs-137 gamma-
rays and only one for X-rays, this set-up did not allow us to
investigate if the differences in radiation physics parameters
between Cs-137 gamma-rays, Co-60 gamma-rays and X-rays
had an effect on the slopes of the MN dose response curve
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Figure 4. Comparison of the dose estimates obtained by scoring 1, 2 or 4 slides in automated (a), semi-automated (b) or manual mode (c). Dose estimations for the
0.85 Gy and the 2.70 Gy dose points are given for each lab. The dotted lines represent the uncertainty intervals.
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and on the dose estimation performed. One lab that reported
unacceptable dose estimates for all blind samples during the
first IC exercise (L4, Table 4(a)) made a new calibration curve
and obtained acceptable dose estimates during the second IC
exercise (Table 4(b)). The largest inter-lab variations in MN
dose response curves were seen for the manual micronucleus
scoring method performed on Giemsa-stained slides. Such
diversity may be related to slight differences in the individual
MN protocols, to scoring criteria or to the quality of the
microscope slides. An inter-lab comparison of MN slides and
scoring criteria was conducted and revealed large variations
in MN numbers scored on the same slide by different labs.
These variations are related to the rigorousness in judging
the slide quality and to the stringency applying the criteria
for identifying binucleate cells and micronuclei. Differences in
manual micronucleus scoring are often related to the follow-
ing criteria: (i) binucleate cell or not, nuclei and micronuclei
can touch/overlap; (ii) the staining intensity of the cytoplasm
of the binucleate cell; (iii) size and staining intensity of micro-
nuclei. For automated and semi-automated scoring the labs
applied the same protocol and MN classifiers. Nevertheless,
differences were still present. The experience with L4 that set
up a new calibration curve in IC2, further pointed to the
importance of strictly following the same procedure to pro-
cess the slides for the calibration curve samples and for the
blind samples. Besides using a standardized culture and fix-
ation procedure, other steps appeared to be very critical,
such as the time between cell fixation and the preparation of
the slide. When cells are stored in fixative solutions for long
periods (e.g. months) at 4 C or 20 C variable results can be
obtained. Often the cells shrink, the nuclei become smaller
and the cytoplasm is more darkly stained, making it more dif-
ficult to score micronuclei in Giemsa-stained cells. When per-
forming automated scoring on DAPI-stained slides the
classifier will select another class of BN cells (based on size)
and in general less MN are detected, probably due to the fact
that more MN may touch or overlap the main nuclei.
Optimally, slides should be prepared and stained within few
days after fixation. The time between staining of the slide
with fluorescent DAPI-stain and scoring the slide should also
be kept uniform. For instance, when slides are scanned imme-
diately after staining, the full staining intensity is not yet
reached and this can influence the results. One should wait
about 1 h before scanning the slides.
From these findings we concluded that in a large network
of labs, a reliable dose estimate will only be obtained when it
is based on the individual lab’s calibration curve which is set
up under the same conditions as the test sample. In the
NATO and the Canadian intercomparison studies (Romm et al.
2013; Wilkins et al. 2015), the dose estimates were also based
on the individual lab’s calibration curve and a wide variation
in MN calibration curves was also reported in the NATO study
(Romm et al. 2013). Only in the MultiBioDose study, where
automated or semi-automated analysis was performed using
the same automated system (Metafer 4, MNScore, Metasystems)
and classifier, a common MN calibration curve was generated
by averaging the data of four separate labs. With this common
calibration curve reliable dose estimates were obtained
(Thierens et al. 2014).
Wide inter-laboratory variations were also observed for the
MN values of the blind dose samples. When grouping the MN
values per scoring method, the highest MN values were in
general obtained with the manual scoring method for the
high-dose samples and PBD simulated sample (Table 3a and
b). Lower MN yields in the high-dose range, obtained when
comparing automated with manual MN scores, were also
observed by Willems et al. (2010) and Varga et al. (2004).
Such an effect is presumed to be caused by more stringent
scoring criteria for BN cells and MN implemented in auto-
mated systems.
In the sham-irradiated sample, higher MN yields were
scored with the automated method, which has also been
reported in previous studies (Willems et al. 2010; Baeyens
et al. 2011; Thierens et al. 2014). The MultiBioDose study by
Thierens et al. (2014), analyzed spontaneous MN values in a
population of 200 healthy individuals by automated and
semi-automated scoring and mean MN values of 43MN/1000
BN cells versus 13MN/1000 BN cells were obtained, respect-
ively. This drop in MN number, occurring in the semi-auto-
mated system after a visual check of the binucleate cell class
with MN, can be attributed to manual correction for false
positive MN, representing mainly background noise.
In the period of time between the two intercomparisons
training was offered to those labs that wanted to re-establish
or improve their competence in the MN assay. Only two labs
(L6, L10) took this opportunity. Although there was an
improvement in dose estimation in IC2 compared to IC1 for
these two labs, the sample size was too small to draw any
conclusions. To achieve a more uniform MN analysis, an
online MN training survey, focusing on both semi-automated/
automated (Metafer4, DAPI-stained cells) and manual
(Giemsa-stained sells) MN scoring, was developed by the
coordinating laboratory and made available on the RENEB
website. To further harmonize the practices of the different
labs in the RENEB network and minimize the discrepancies in
the calculated doses a quality manual (QA & QM manual),
based on ISO standards (Voisin et al. 2002), was produced
within the RENEB project for the various biological and phys-
ical dosimetry techniques used in the network (Gregoire et al.
2016). Performance of the CBMN assay according to QA and
QM procedures should guarantee more accurate and compar-
able dose estimates among the network partners irrespective
of the labs’ specific MN protocol.
Although in this study a lot of variation was observed in
the MN yields obtained with all scoring methods and for all
dose points, the dose estimations obtained by using individ-
ual labs calibration curves and Dose estimate or CABAS soft-
ware, were acceptably accurate. The best dose estimations
were obtained for the sham-irradiated controls and the low-
dose points. For the sham-irradiated controls, 88% of the
dose estimates were classified correctly using the 0.5 Gy
uncertainty interval for triage dosimetry. The low-dose points
of 0.85 and 0.94 Gy showed dose estimates that were correct
in 88% and 84% of cases, respectively.
With the high dose points, the percentages of correctly
classified doses, using the 20% deviation from the true dose
for triage dosimetry, was lower: 47% for the 3.27 Gy dose in
IC1 and 74% for the 2.7 Gy dose in IC2. However, when using
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the triage categories defined in the MultiBioDose guidance
(triage categories: low dose 0–1Gy; medium dose: 1–2Gy;
high dose >2Gy) (Jaworska et al. 2015), 15 out of 17 dose
estimates (88%) were placed in the correct triage category for
the high-dose point of 3.27 Gy in IC1, whereas for the 2.7 Gy
dose in IC2, 23 out of 24 estimates (96%) were classified in
the correct dose range category.
Low MN yields were obtained for the PB simulated dose
sample, which was not unexpected. From previous studies
performed in the framework of the MultiBioDose project it
was shown that for heterogeneous exposed blood samples
(>4Gy) the MN yields drop due to radiation-induced prolifer-
ation inhibition in this dose range, resulting in low and unreli-
able dose estimates (Thierens et al. 2014). Although MN
frequency distributions in general are overdispersed in
respect to the Poisson distribution, yielding r2/l values >1
as was also observed in this study for the homogeneous irra-
diated samples, the study of Thierens et al. reported that
high values of r2/l (1.8–2.5) can be used as an indicator for
partial-body irradiation. In this intercomparison exercise all
labs, except one, were able to identify the partial-body dose
simulated sample based on a r2/l 1.5. According to
Thierens et al. the use of the r2/l value in partial body expo-
sures necessitates semi-automated scoring, as only in this
scoring method can r2/l be determined with sufficient accur-
acy. In the present study values of r2/l 1.5 were obtained
with all MN scoring methods. Using the triage categories
defined in the MultiBioDose guidance, all dose estimate val-
ues for the PB dose sample were higher than 2Gy and thus
correctly classified in the high dose triage category. The mean
value (%) that was calculated for the fraction of the body irra-
diated was 55%, which is very close to the experimental condi-
tion in which irradiated and non-irradiated blood was mixed in
a 1:1 ratio (50%).
When comparing the accuracy of the three scoring meth-
ods, it was observed that for the sham-irradiated sample and
the simulated acute whole body doses in IC1 and IC2, the
semi-automated method, which implies the visual inspection
of galleries of MN-positive binucleate cells, is the most accur-
ate method for triage purposes, with 73% (in IC1) and 100%
(88% when non-RENEB partners were included) (in IC2) cor-
rectly classified doses using the 0.5 Gy and 20% deviation
from the true dose as uncertainty intervals. Also the mean
dose estimate values in IC2, obtained by pooling the results
of the participating labs, are nearest to the true doses and
the SEM are smallest for the semi-automated scoring method
(Table 4(a) and (b)). These findings are in agreement with
those of the MultiBioDose study (Thierens et al. 2014) in
which it was also shown that, compared to automated scor-
ing, semi-automated scoring improves the accuracy of the
dose estimation. In the NATO study (Romm et al. 2013), satis-
factory results were obtained with all scoring methods,
although the number of labs performing semi-automated
analysis was very small (n¼ 2). Although the best results were
obtained with the semi-automated scoring method in our
study, acceptable mean dose estimates with small SEM were
also obtained with both the automated and the manual scor-
ing methods. These results indicate that all three scoring
methods are suitable for triage biodosimetry.
In an emergency situation, dose estimates should be pro-
vided as soon as possible to support critical clinical decision
making, and a high throughput scoring method is preferable
for triage biodosimetry. Both automated and semi-automated
scoring allows rapid and reproducible analysis. However, not
all labs having expertise in biodosimetry are equipped with
an automated system and manual scoring will also remain a
widely used technique in the near future. In this context, spe-
cific strategies aimed at minimizing the number of BN cells to
be scored should be adopted.
Currently the IAEA recommendation is to analyze 200 BN
cells manually for the CBMN assay in triage mode, thus mak-
ing MN evaluation comparable to the triage mode of dicen-
trics (McNamee et al. 2009; Flegal et al. 2010). Our results
demonstrated that there is no significant difference in dose
estimation accuracy when 2000 or 500 binucleate cells are
manually scored.
Conclusion
The results of the two micronucleus intercomparison exercises
performed by the RENEB network, demonstrate that the cyto-
kinesis-block MN assay is a useful triage tool for large-scale
radiation emergencies. In general, acceptable dose estimates
were obtained by the RENEB partners for all three scoring
methods adopted, although higher accuracy was achieved
with the semi-automated method. The increase in the num-
ber of acceptable dose estimates in the second IC exercise
compared to the first IC exercise further points to the need
for a strong training program to refine the capacity of a bio-
dosimetry network for existing and potentially new members.
It also stresses the importance of performing regular inter-
comparison training exercises within a specialized biodosime-
try network.
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